Catamenial epilepsy: Definition, prevalence pathophysiology and treatment

Seizure

Volumn 17, Issue 2, 2008, Pages 151-159

  Herzog, Andrew G ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Catamenial; Epilepsy; Hormone; Reproductive

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOMIFENE; ESTRADIOL; GESTAGEN; GONADORELIN; GOSERELIN; LEUPRORELIN; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; NEUROSTEROID; PHENOBARBITAL; PHENYTOIN; PLACEBO; PROGESTERONE; STERYL SULFATASE; TRIPTORELIN; VALPROIC ACID;

ANOVULATION; ARTICLE; CATAMENIAL EPILEPSY; CLINICAL TRIAL; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FOLLOW UP; HORMONAL THERAPY; HORMONE SENSITIVITY; HUMAN; LOZENGE; LUTEAL PHASE; MENSTRUAL CYCLE; MONOTHERAPY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ANIMALS; ANTICONVULSANTS; CIRCADIAN RHYTHM; EPILEPSY; FEMALE; HUMANS; MALE; MENSTRUAL CYCLE;

EID: 38949124727     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2007.11.014     Document Type: Article

References (64)

1. Tauboll E., Lundervold A., and Gjerstad L. Temporal distribution of seizures in epilepsy. Epilepsy Res 8 (1991) 153-165
2. Fowler K., Massaro J., Harden C., Liporace J., Pennell P., Schomer D., et al. Distribution of seizure occurrence in women with epilepsy: preliminary data analysis in a prospective multicenter investigation. Epilepsia 47 (2006) 1
3. Almqvist R. The rhythm of epileptic attacks and its relationship to the menstrual cycle. Acta Psychiatr Neurol Scand 30 Suppl. 105 (1955) 1-116
4. Herzog A.G., Klein P., and Ransil B.J. Three patterns of catamenial epilepsy. Epilepsia 38 (1997) 1082-1088
5. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 54 (1976) 321-347
6. Laidlaw J. Catamenial epilepsy. Lancet 271 (1956) 1235-1237
7. Herzog A.G., Harden C.L., Liporace J., Pennell P., Schomer D.L., Sperling M., et al. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol 56 (2004) 431-434
8. McEwen B.S. How do sex and stress hormones affect nerve cells?. Ann N Y Acad Sci 743 (1994) 1-16
9. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J 6 (1992) 2311-2322
10. Klein P., and Herzog A.G. Endocrine aspects of epilepsy. In: Pretel S., Knigge K.M., and Prasad A. (Eds). Neuroendocrine and neuromolecular aspects of epilepsy and brain disorders (1997), Research Signpost, Trivandrum, India 111-140
11. Smith S.S. Estrogen administration increases neuronal responses to excitatory amino acids as a long term effect. Brain Res 503 (1989) 354-357
12. Wong M., and Moss R. Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J Neurosci 12 (1992) 3217-3225
13. Kawakami M., Teresawa E., and Ibuki T. Changes in multiple unit activity in the brain during the estrous cycle. Neuroendocrinol 6 (1970) 30-48
14. Woolley C.S., and McEwen B.S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 336 (1993) 293-306
15. Woolley C.S., and McEwen B.S. Estradiol regulates hippocampal dendritic spine density via an N-methyl-d-aspartate receptor-dependent mechanism. J Neurosci 14 (1994) 7680-7687
16. Pfaff D.W., and Keiner M. Estradiol-concentrating cells in the rat amygdala as part of a limbic-hypothalamic hormone-sensitive system. In: Eleftheriou B. (Ed). The neurobiology of the amygdala (1973), Plenum Publishing, New York 775-792
17. Simerly R.B., Chang C., Muramatsu M., and Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 294 (1990) 76-95
18. McEwen B.S. Nongenomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 12 (1991) 141-147
19. A receptor complex. J Pharmacol Exp Ther 265 (1993) 1374-1379
20. Wallis C.J., and Luttge W.G. Influence of estrogen and progesterone on glutamic acid decarboxylase activity in discrete regions of rat brain. J Neurochem 34 (1980) 609-613
21. Luine V.N., Renner K.J., and McEwen B.S. Sex-dependent differences in estrogen regulation of choline acetyltransferase are altered by neonatal treatments. Endocrinology 119 (1986) 874-878
22. Teresawa E., and Timiras P. Electrical activity during the estrous cycle of the rat; cyclic changes in limbic structures. Endocrinology 83 (1968) 207
23. Logothetis J., and Harner R. Electrocortical activation by estrogens. Arch Neurol 3 (1960) 290-297
24. Marcus E.M., Watson C.W., and Goodman P.L. Effects of steroids on cerebral electrical activity. Arch Neurol 15 (1966) 521-532
25. Hom A.C., and Buterbaugh G.G. Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulation or pentylenetetrazol administration in ovariectomized female rats. Epilepsia 27 (1986) 103-108
26. Nicoletti F., Speciale C., Sortino M.A., Summa G., Caruso G., Patti F., et al. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia 26 (1985) 252-257
27. Spiegel E., and Wycis H. Anticonvulsant effects of steroids. J Lab Clin Med 30 (1945) 947-953
28. Woolley D.E., and Timiras P.S. The gonad-brain relationship: effects of female sex hormones on electroshock convulsions in the rat. Endocrinology 70 (1962) 196-209
29. Veliskova J., Velisek L., Galanopoulou A.S., and Sperber E.F. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 41 Suppl. 6 (2000) S30-S35
30. Logothetis J., Harner R., Morrell F., and Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology (Minneap) 9 (1959) 352-360
31. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
32. Gee K.W., McCauley L.D., and Lan N.C. A putative receptor for neurosteroids on the GABA receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol 9 (1995) 207-227
33. Phyllis J.W. Potentiation of the depression by adenosine of rat cerebral cortex neurones by progestational agents. Br J Pharmacol 89 (1986) 693-702
34. Valera S., Ballivet M., and Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 89 (1992) 9949-9953
35. Hsueh A.J.W., Peck E.J., and Clark J.H. Control of uterine estrogen receptor levels by progesterone. Endocrinology 98 (1976) 438-444
36. Frye C.A. The neurosteroid 3a-5a-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res 696 (1995) 113-120
37. Smith S.S., Waterhouse B.D., and Woodward D.J. Sex steroid effects on extrahypothalamic CNS. II. Progesterone, alone and in combination with estrogen, modulates cerebellar responses to amino acid neurotransmitters. Brain Res 422 (1987) 52-62
38. Landgren S., Backstrom T., and Kalistratov G. The effect of progesterone on the spontaneous interictal spike evoked by the application of penicillin to the cat's cerebral cortex. J Neurol Sci 36 (1978) 119-133
39. Backstrom T., Zetterlund B., Blom S., and Romano M. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol Scand 69 (1984) 240-248
40. A receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 8 (2005) 797-804
41. Wu F.S., Gibbs T.T., and Farb D.H. Inverse modulation of g-aminobutyric acid- and glycine-induced currents by progesterone. Mol Pharmacol 37 (1990) 597-602
42. Cheney D.L., Uzunov D., Costa E., and Guidotti A. Gas chromatographic-mass fragmentographic quantitation of 3a-hydroxy-5a-pragnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J Neurosci 15 (1995) 4641-4650
43. Belleli D., Bolger M.B., and Gee K.W. Anticonvulsant profile of the progesterone metabolite 5a-pregnan-3a-ol-20-one. Eur J Pharmacol 166 (1989) 325-329
44. Kokate T.G., Svensson B.E., and Rogawski M.A. Anticonvulsant activity of neurosteroids: correlation with g-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 270 (1994) 1223-1229
45. Kokate T.G., Cohen A.L., Karp E., and Rogawski M.A. Neuroactive steroids protect against pilocarpine-and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology 35 (1996) 1049-1056
46. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392 (1998) 926-930
47. 2+ in cultured rat hippocampal neurons. Neurosci Lett 141 (1992) 30-34
48. Heuser G., Ling G.M., and Buchwald N.A. Sedation or seizures as dose-dependent effects of steroids. Arch Neurol 13 (1965) 195-203
49. Levesque L.A., Herzog A.G., and Seibel M.M. The effect of phenytoin and carbamazepine on dehydroepiandrosterone sulfate in men and women who have partial seizures with temporal lobe involvement. J Clin Endocrinol Metab 63 (1986) 243-245
50. Herzog A.G., Drislane F.W., Schomer D.L., Pennell P.B., Bromfield E.B., Kelly K.M., et al. Differential antiepileptic drug effects on sexual function and reproductive hormones: interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs. Epilepsia 45 (2004) 764-768
51. Dana Haeri J., and Richens A. Effect of norethistrone on seizures associated with menstruation. Epilepsia 24 (1983) 377-381
52. Mattson R.H., Cramer J.A., Caldwell B.V., and Siconolfi B.C. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology (Cleveland) 34 (1984) 1255-1258
53. Herzog A.G. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 36 (1986) 1607-1610
54. Herzog A.G. Progesterone therapy in complex partial and secondary generalized seizures. Neurology 45 (1995) 1660-1662
55. Herzog A.G. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 52 (1999) 1917-1918
56. Herzog A.G., and Frye C.A. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol 53 (2003) 390-391
57. Herzog A.G., Friedman M.N., Freund S., and Pascual-Leone A. Transcranial magnetic stimulation evidence of a potential role for progesterone in the modulation of premenstrual cortico-cortical inhibition in a woman with catamenial seizure exacerbation. Epilepsy Behav 2 (2001) 367-369
58. Zimmerman A.W., Holden K.R., Reiter E.O., and Dekaban A.S. Medroxyprogesterone acetate in the treatment of seizures associated with menstruation. J Pediatr 83 (1973) 959-963
59. Hall S.M. Treatment of menstrual epilepsy with a progesterone-only oral contraceptive. Epilepsia 18 (1977) 235-236
60. Bauer J., Wildt L., Flugel D., and Stefan H. The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients. J Neurol 239 (1992) 284-286
61. Haider Y., and Barnett D.B. Catamenial epilepsy and goserelin. Lancet 338 (1991) 1530
62. Reid B., and Gangar K.F. Catamenial epilepsy and goserelin. Lancet 339 (1992) 253
63. Finkelstein J.S., Klibenski A., Schaefer E.H., Hornstein M.D., Schiff I., and Neer R.M. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. New Engl J Med 331 (1994) 1618-1623
64. Herzog A.G. Reproductive endocrine considerations and hormonal therapy for women with epilepsy. Epilepsia 32 (1991) S27-S33